In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 412-418

  Lincopan, Nilton ^a   Mamizuka, Elsa M ^a   Carmona Ribeiro, Ana M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amphotericin B; Drug delivery; In vivo

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CATION; MONOMER; ORGANIC SOLVENT; PLACEBO; WATER;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; DISPERSION; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; FEMALE; IN VIVO STUDY; KIDNEY; LIGHT ABSORPTION; LIGHT SCATTERING; MOUSE; NONHUMAN; PARTICLE SIZE; POWDER; SPLEEN; SURVIVAL; ULTRASOUND; ULTRAVIOLET RADIATION;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; CANDIDIASIS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; COLLOIDS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; LIPID BILAYERS; MICE; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; SCATTERING, RADIATION; SPECTROPHOTOMETRY, ULTRAVIOLET; SURVIVAL ANALYSIS;

EID: 0141741201     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg383     Document Type: Article

References (42)

1. Fridkin, S. K. & Jarvis, W. R. (1996). Epidemiolology of nosocomial fungal infections. Clinical Microbiology Reviews 9, 499-511.
2. Bodey, G., Bueltmann, B., Duguid, W. et al. (1992). Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases 11, 99-109.
3. Nucci, M., Colombo, A. L., Silveira, F. et al. (1998). Risk factors for death in patients with candidemia. Infection Control and Hospital Epidemiology 19, 846-50.
4. Wenzel, R. P. (1995). Nosocomial candidemia: risk factors and attributable mortality. Clinical Infectious Diseases 20, 1531-4.
5. Dekruijff, B. & Demel, R. A. (1974). Polyene antibiotic-sterol interactions in membranes of acholeplasma-laidlawii cells and lecithin liposomes. 3. Molecular structure of polyene antibiotic-cholesterol complexes. Biochimica et Biophysica Acta 339, 57-70.
6. Dekruijff, B., Gerritse, W. J., Oerleman, A. et al. (1974). Polyene antibiotic-sterol interactions in membranes of acholeplasma-laidlawii cells and lecithin liposomes. 1. Specificity of membrane-permeability changes induced by polyene antibiotics. Biochimica et Biophysica Acta 339, 30-43.
7. Andreoli, T. E. (1973). On the anatomy of amphotericin B-cholesterol pores in lipid bilayer membranes. Kidney International 4, 337-45.
8. Gallis, H. A., Drew, R. H. & Pickard, W. W. (1990). Amphotericin B: 30 years of clinical experience. Reviews of Infectious Diseases 12, 308-29.
9. Barwicz, J., Christian, S. & Gruda, I. (1992). Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrobial Agents and Chemotherapy 36, 2310-5.
10. Brajtburg, J. & Bolard, J. (1996). Carrier effects on biological activity of amphotericin B. Clinical Microbiology Reviews 9, 512-31.
11. Lopez- Berestein, G. (1987). Liposomes as carrier of antimicrobial agents. Antimicrobial Agents and Chemotherapy 31, 675-8.
12. Tancrède, P., Barwicz, J., Jutras, S. et al. (1990). The effect of surfactants on the aggregation state of amphotericin B. Biochimica et Biophysica Acta 1030, 289-95.
13. Souza, L. C., Maranhao, R. C., Schreier, S. et al. (1993). In-vitro and in-vivo studies of the decrease of amphotericin-B toxicity upon association with a triglyceride-rich emulsion. Journal of Antimicrobial Chemotherapy 32, 123-32.
14. Souza, L. C. & Campa, A. (1999). Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion. Journal of Antimicrobial Chemotherapy 44, 77-84.
15. Zarif, L., Graybill, J. R., Perlin, D. et al. (2000). Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrobial Agents and Chemotherapy 44, 1463-9.
16. Santangelo, R., Paderu, P., Delmas, G. et al. (2000). Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrobial Agents and Chemotherapy 44, 2356-60.
17. Maschmeyer, G. (2002). New antifungal agents - treatment standards are beginning to grow old. Journal of Antimicrobial Chemotherapy 49, 239-41.
18. Campanhã, M. T. N., Mamizuka, E. M. & Carmona-Ribeiro, A. M. (2001). Interactions between cationic vesicles and Candida albicans. Journal of Physical Chemistry B 105, 8230-6.
19. Carmona-Ribeiro, A. M. & Chaimovich, H. (1983). Preparation and characterization of large dioctadecyldimethylammonium chloride liposomes and comparison with small sonicated vesicles. Biochimica et Biophysica Acta 733, 172-9.
20. Carmona-Ribeiro, A. M. (1992). Synthetic amphiphile vesicles. Chemical Society Reviews 21, 209-14.
21. Carmona-Ribeiro, A. M. (2001). Bilayer vesicles and liposomes as interface agents. Chemical Society Reviews 30, 241-7.
22. Katz, A., Kraaijeveld, C. A. & Snippe, H. (1994). Synthetic lipoid compounds as antigen-specific immunostimulators for improving the efficacy of killed-virus vaccines. In The Theory and Practical Application of Adjuvants (Stewart-Tull, D. E. S., Ed.), p. 37-50. John Wiley and Sons Ltd, New York, NY, USA.
23. Veronesi, R., Correa, A. & Alterio, D. (1970). Single dose immunization against tetanus. Promising results in human trials. Revista do Instituto de Medicina Tropical de São Paulo 12, 46-54.
24. Tsuruta, L. R., Quintilio, W., Costa, M. H. B. et al. (1997). Intercation between cationic liposomes and an antigenic protein: the physical chemistry of the immunoadjuvant action. Journal of Lipid Research 38, 2003-11.
25. Tapias, G. N., Sicchierolli, S. M., Mamizuka, E. M. et al. (1994). Interactions between cationic vesicles and Escherichia coli. Langmuir 10, 3461-5.
26. Sicchierolli, S. M., Mamizuka, E. M. & Carmona-Ribeiro, A. M. (1995). Bacteria flocculation and death by cationic vesicles. Langmuir 11, 2991-5.
27. Martins, L. M. S., Mamizuka, E. M. & Carmona-Ribeiro, A. M. (1997). Cationic vesicles as bactericides. Langmuir 13, 5583-7.
28. Campanhã, M. T. N., Mamizuka, E. M. & Carmona-Ribeiro, A. M. (1999). Interactions between cationic liposomes and bacteria: the physical-chemistry of the bactericidal action. Journal of Lipid Research 40, 1495-500.
29. Carmona-Ribeiro, A. M., Ortis, F., Schumacher, R. I. et al. (1997). Interactions between cationic vesicles and cultured mammalian cell. Langmuir 13, 2215-8.
30. Vieira, D. B. & Carmona-Ribeiro, A. M. (2001). Synthetic bilayer fragments for solubilization of amphotericin B. Journal of Colloid and Interface Science 244, 427-31.
31. Pacheco, L. F. & Carmona-Ribeiro, A. M. (2003). Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. Journal of Colloid and Interface Science 254, 146-54.
32. Schales, O. & Schales, S. S. (1941). A simple and accurate method for the determination of chloride in biological fluids. Journal of Biological Chemistry 140, 879-83.
33. Trissel, L. A. (1988). Amphotericin B. In Handbook on Injectable Drugs, (Trissel, L. A., Ed.), pp. 50-3. American Society of Hospital Pharmacists, Bethesda, MD, USA.
34. Grabowski, E. & Morrison, I. (1983). Particle size distribution from analysis of quasi-elastic light scattering data. In Measurements of Suspended Particles by Quasi-Elastic Light Scattering (Dahneke, B., Ed.), p. 199-236. Wiley-Interscience, New York, NY, USA.
35. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard M27-A. NCCLS, Wayne, PA, USA.
36. Knapp, C. & Moody, J. A. (1992). Tests to assess bactericidal activity. In Clinical Microbiology Procedures Handbook (Isenberg, H. D., Ed.), p. 5.16.1-33. American Society for Microbiology, Washington, DC, USA.
37. Schmidt, A. (1999). A generalized Candida albicans infection model in the rat. In Handbook of Animal Models of Infection (Zak, O. & Sande, M. A., Eds), p. 657-62. Academic Press, San Diego, CA, USA.
38. Siglin, J. C. & Rutledge, G. M. (1995). Laboratory animal management. In CRC Handbook of Toxicology (Derelanko, M. J. & Hollinger, M. A., Ed.), p. 1-50. CRC Press, Boca Raton, FL, USA.
39. Schreier, S., Malheiros, S. V. P. & De Paula, E. (2000). Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochimica et Biophysica Acta 1508, 210-34.
40. Carmona-Ribeiro, A. M. (2001). Interaction between bilayer vesicles, biomolecules, and interfaces. In Handbook of Surfaces and Interfaces of Materials, Vol. V (Nalwa, H. S., Ed.), p. 129-65. Academic Press, San Diego, CA, USA.
41. Carvalho, L. A. & Carmona-Ribeiro, A. M. (1998) Interactions between cationic vesicles and serum proteins. Langmuir 14, 6077-81.
42. Dupont, B. (2002) Overview of the lipid formulations of amphotericin B. Journal of Antimicrobial Chemotherapy 49, 31-6.